News
Anbio Biotechnology strengthens its position in the NASDAQ Composite by extending its diagnostics capabilities beyond ...
WNS experiences a downgrade as broader sector impact performance within the NYSE Composite, reflecting shifting market dynamics and operational reassessments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback